Varga A, Palmai Z, Gugolya Z, Gráczer É, Vonderviszt F, Závodszky P, Balog E, Vas M (December 2012). “Importance of aspartate residues in balancing the flexibility and fine-tuning the catalysis of human 3-phosphoglycerate kinase”. 《Biochemistry》 51 (51): 10197–207. doi:10.1021/bi301194t. PMID23231058.
Cliff MJ, Bowler MW, Varga A, Marston JP, Szabó J, Hounslow AM, Baxter NJ, Blackburn GM, Vas M, Waltho JP (May 2010). “Transition state analogue structures of human phosphoglycerate kinase establish the importance of charge balance in catalysis”. 《Journal of the American Chemical Society》 132 (18): 6507–16. doi:10.1021/ja100974t. PMID20397725.
Bernstein BE, Hol WG (March 1998). “Crystal structures of substrates and products bound to the phosphoglycerate kinase active site reveal the catalytic mechanism”. 《Biochemistry》 37 (13): 4429–36. doi:10.1021/bi9724117. PMID9521762.
Larsson-Raźnikiewicz M (Jan 1967). “Kinetic studies on the reaction catalyzed by phosphoglycerate kinase. II. The kinetic relationships between 3-phosphoglycerate, MgATP2-and activating metal ion”. 《Biochimica et Biophysica Acta (BBA) - Enzymology》 132 (1): 33–40. doi:10.1016/0005-2744(67)90189-1. PMID6030358.
Varga A, Chaloin L, Sági G, Sendula R, Gráczer E, Liliom K, Závodszky P, Lionne C, Vas M (June 2011). “Nucleotide promiscuity of 3-phosphoglycerate kinase is in focus: implications for the design of better anti-HIV analogues”. 《Molecular BioSystems》 7 (6): 1863–73. doi:10.1039/c1mb05051f. PMID21505655.
Larsson-Raźnikiewicz, Märtha; Wiksell, Eva (1978년 3월 1일). “Inhibition of phosphoglycerate kinase by salicylates”. 《Biochimica et Biophysica Acta (BBA) - Enzymology》 523 (1): 94–100. doi:10.1016/0005-2744(78)90012-8. PMID343818.
Varga A, Palmai Z, Gugolya Z, Gráczer É, Vonderviszt F, Závodszky P, Balog E, Vas M (December 2012). “Importance of aspartate residues in balancing the flexibility and fine-tuning the catalysis of human 3-phosphoglycerate kinase”. 《Biochemistry》 51 (51): 10197–207. doi:10.1021/bi301194t. PMID23231058.
Cliff MJ, Bowler MW, Varga A, Marston JP, Szabó J, Hounslow AM, Baxter NJ, Blackburn GM, Vas M, Waltho JP (May 2010). “Transition state analogue structures of human phosphoglycerate kinase establish the importance of charge balance in catalysis”. 《Journal of the American Chemical Society》 132 (18): 6507–16. doi:10.1021/ja100974t. PMID20397725.
Bernstein BE, Hol WG (March 1998). “Crystal structures of substrates and products bound to the phosphoglycerate kinase active site reveal the catalytic mechanism”. 《Biochemistry》 37 (13): 4429–36. doi:10.1021/bi9724117. PMID9521762.
Larsson-Raźnikiewicz M (Jan 1967). “Kinetic studies on the reaction catalyzed by phosphoglycerate kinase. II. The kinetic relationships between 3-phosphoglycerate, MgATP2-and activating metal ion”. 《Biochimica et Biophysica Acta (BBA) - Enzymology》 132 (1): 33–40. doi:10.1016/0005-2744(67)90189-1. PMID6030358.
Varga A, Chaloin L, Sági G, Sendula R, Gráczer E, Liliom K, Závodszky P, Lionne C, Vas M (June 2011). “Nucleotide promiscuity of 3-phosphoglycerate kinase is in focus: implications for the design of better anti-HIV analogues”. 《Molecular BioSystems》 7 (6): 1863–73. doi:10.1039/c1mb05051f. PMID21505655.
Larsson-Raźnikiewicz, Märtha; Wiksell, Eva (1978년 3월 1일). “Inhibition of phosphoglycerate kinase by salicylates”. 《Biochimica et Biophysica Acta (BBA) - Enzymology》 523 (1): 94–100. doi:10.1016/0005-2744(78)90012-8. PMID343818.
Yoshida A, Tani K (1983). “Phosphoglycerate kinase abnormalities: functional, structural and genomic aspects”. 《Biomedica Biochimica Acta》 42 (11–12): S263–7. PMID6689547.